Mikulinsky Oleg 4

4 · CRYO CELL INTERNATIONAL INC · Filed Jan 9, 2026

Form 4

Period: 2026-01-07

Chief Information Officer

Transactions

Award
Stock Option
2026-01-07$3.54/sh+10,000$35,400→ 10,000 total
Exercise: $3.54From: 2026-01-07Exp: 2031-01-07→ Common Stock (10,000 underlying)
Award
Stock Option
2026-01-07$3.54/sh+20,000$70,800→ 20,000 total
Exercise: $3.54From: 2026-01-07Exp: 2031-01-07→ Common Stock (20,000 underlying)

Holdings

Common Stock
104,349
Stock Option
Exercise: $7.49From: 2018-05-21Exp: 2028-05-21→ Common Stock (8,000 underlying)
8,000
Stock Option
Exercise: $7.13From: 2019-09-04Exp: 2029-09-04→ Common Stock (4,444 underlying)
4,444
Stock Option
Exercise: $6.55From: 2020-02-27Exp: 2030-02-27→ Common Stock (1,333 underlying)
1,333
Stock Option
Exercise: $8.00From: 2021-09-23Exp: 2028-09-23→ Common Stock (10,000 underlying)
10,000
Stock Option
Exercise: $11.90From: 2021-12-28Exp: 2028-12-28→ Common Stock (20,000 underlying)
20,000
Stock Option
Exercise: $5.88From: 2023-12-22Exp: 2028-12-22→ Common Stock (10,000 underlying)
10,000
Stock Option
Exercise: $7.35From: 2025-01-21Exp: 2030-01-21→ Common Stock (10,000 underlying)
10,000

Footnotes (6)

[F1]Stock options vest 1/5 per year commencing on September 23, 2021.
[F2]Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven year option period.
[F3]Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
[F4]Stock options vest 1/3 upon issuance, 1/3 on January 22, 2026 and 1/3 on January 22, 2027.
[F5]Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028.
[F6]The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company.

Documents

1 file